Clicky

China Medical Sys Hlds(CHSYF)

Description: China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products to hospital and medical institutions in the People's Republic of China. It offers products under the direct and agency networks. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for the treatment of blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise Tanshinone capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu, for treating respiratory diseases; Ganfule capsules for the treatment of primary carcinoma of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for bone pains; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. It also engages in the agriculture business. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.


Keywords: Clinical Medicine Pharmaceutical Products Infection Hypertension Hepatitis Hepatitis B Depression Heart Failure Liver Disease Respiratory Diseases Ulcer Ulcerative Colitis Cholesterol Crohn's Disease Carcinoma Diarrhea Heart Disease Colitis Constipation Flux Angina Sterol Anxiety Coronary Artery Disease Ngg Gastritis Rcti Myocardial Infarction Treatment Of Hypertension Chronic Hepatitis B Chronic Heart Failure Fungal Infections Asos Coronary Heart Disease Fungal Infection Angina Pectoris Infarction Pains Acute Heart Failure Chronic Constipation Eye Drop Hepatitis A Mastitis Pepsi Asthenopia Carbuncle Cellulitis Lamisil Otitis Tonsillitis Treatment Of Acute Heart Failure Treatment Of Diarrhea Acute Hepatitis A Biliary Reflux Gastritis Boils Cholestatic Liver Disease Cholesterol Gallstones Illit Mixed Angina Osteomyelitis Otitis Externa Parlodel Protein Hydrolysate Oral Solution Stable Angina Pectoris Superficial Phlebitis Traumatic Infection Treatment Of Coronary Heart Disease

Home Page: www.cms.net.cn

Island Place Tower
North Point,
Hong Kong
Phone: 852 2369 7678


Officers

Name Title
Mr. Kong Lam Founder, Chairman, CEO & Pres
Ms. Yanling Chen CFO, VP & Exec. Director
Mr. Hongbing Chen COO, VP, Director of Sales & Marketing and Exec. Director
Dr. Wai Ming Wong Chief Technical Officer
Ms. Sanyan Wu Director of Legal Department & Company Sec.

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 7.2254
Trailing PE: 7.2684
Price-to-Book MRQ: 1.7074
Price-to-Sales TTM: 0.4514
IPO Date:
Fiscal Year End: December
Full Time Employees: 5454
Back to stocks